ArticleCureus2026
Clinical Experience of Craniospinal Irradiation Using Volumetric Modulated Arc Therapy on the Siddharth-II Linear Accelerator: A Dosimetric Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimCraniospinal irradiation (CSI) is a technically challenging radiotherapy procedure due to the extended target volume, multiple isocenters, and the need to maintain dose uniformity across junction regions. This study evaluated the feasibility, workflow efficiency, and dosimetric performance of volumetric modulated arc therapy (VMAT)-based CSI delivered using the Siddharth-II O-ring gantry linear accelerator. MATERIALS AND
methodsA retrospective feasibility study was conducted in two patients with cerebral germinoma, treated with a multi-isocenter VMAT-based CSI technique on the Siddharth-II linear accelerator (Bangalore, India: Panacea Medical Technologies Pvt. Ltd.). Treatment planning was carried out in RayStation 12A (Stockholm, Sweden: RaySearch Laboratories) using 6 MV photon beams with three isocenters covering cranial, upper spinal, and lower spinal regions. Junction optimization was achieved using longitudinal overlap regions. Dosimetric evaluation included target coverage parameters (D98, D50, D2), conformity index (CI), homogeneity index (HI), and organ-at-risk (OAR) doses. Treatment delivery efficiency was assessed using monitor units and beam-on time. Patient-specific quality assurance was performed using a 2D detector array with 3%/3 mm gamma analysis. Cone-beam CT-based image guidance and six-degrees-of-freedom couch corrections were used for setup verification.
resultsBoth patients achieved satisfactory target coverage with D98 values of 22.56 Gy and 24.29 Gy and D2 values of 24.19 Gy and 25.77 Gy, respectively. CI and HI values were 1.15 and 1.04, demonstrating favorable conformity and homogeneity. Junction regions showed smooth dose transitions without clinically significant hot or cold spots. Mean lung doses remained below 5 Gy, kidney doses below 6 Gy, and lens doses below 10 Gy. Gamma passing rates exceeded 98%, while treatment delivery times were approximately 8-9 min with total monitor units below 940.
conclusionVMAT-based CSI using the Siddharth-II O-ring gantry linear accelerator is feasible and demonstrates favorable dosimetric performance, effective junction management, reliable quality assurance, and efficient treatment delivery. These findings support the clinical applicability of this platform for complex craniospinal irradiation techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.